Lineage Cell Therapeutics, Inc. (LCTX) News

Latest headlines that mention LCTX, newest first · each headline opens the original publisher

LCTX quote

Last price: $1.00
Day change: +0.29%
Next earnings: 2026-11-05

Quote & chart Expected move Insider trading IV rank history

LCTX headlines

latest coverage

Not much coverage yet. LCTX has appeared in only a few headlines lately; new stories show up here as publishers cover it.

Seeking Alpha News 1mo ago

Lineage Cell Therapeutics: Balancing An Out-Licensed Pipeline Against Clinical Risk

General T2LCTX

Motley Fool 2mo ago

Lineage Cell Therapeutics (LCTX) Q2 2026 Earnings Call Transcript

CEO outlines manufacturing scale-up strategy for cell therapies amid $50.8M cash runway.

Earnings T3LCTX

Yahoo Finance 2mo ago

Lineage Cell Therapeutics Q2 Earnings Call Highlights

Earnings T2LCTX

Seeking Alpha News 2mo ago

Lineage Cell Therapeutics, Inc. (LCTX) Q2 2026 Earnings Call Transcript

Earnings T2LCTX

Seeking Alpha News 3mo ago

Lineage Cell Therapeutics, Inc. (LCTX) Discusses COR1 Cell Transplant Program and Manufacturing Strategy for Corneal Endothelial Disease Transcript

General T2LCTX

Seeking Alpha News 5mo ago

Lineage Cell Therapeutics, Inc. (LCTX) Q1 2026 Earnings Call Transcript

Earnings T2LCTX

Seeking Alpha 5mo ago

Lineage Cell Therapeutics GAAP EPS of -$0.03 misses by $0.01, revenue of $1.72M misses by $1.36M

Earnings T2LCTX

Seeking Alpha 5mo ago

Lineage Cell Therapeutics Q1 2026 Earnings Preview

Earnings T2LCTX

Seeking Alpha News 5mo ago

Lineage Cell Therapeutics, Inc. (LCTX) Presents at FFB Retinal Therapeutics Innovation Summit - Slideshow

General T2LCTX

LCTX news alerts

Get an alert by email or push when a new headline mentions LCTX.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.